Letter: therapeutic drug monitoring and inflammatory bowel disease—a call for an urgent standardization of the results

E-ISSN： 1365-2036|47|3|448-449

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.3, 2018-02, pp. : 448-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: early post‐induction anti‐TNF drug monitoring can predict long‐term therapeutic outcomes in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 436-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: cytomegalovirus infection in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 127-129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter to the Editor: On the Usefulness of Therapeutic Drug Monitoring of Methadone

European Addiction Research, Vol. 6, Iss. 1, 2000-03 ,pp. : 31-33

Karger

Access to resources Recommend Favorite

Drug-Induced Nephrotoxicity in Inflammatory Bowel Disease

Nephron Clin Pract, Vol. 119, Iss. 2, 2011-06 ,pp. : c89-c96

Karger

Access to resources Recommend Favorite

Letter: thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 494-495

John Wiley & Sons Inc

Access to resources Recommend Favorite